Literature DB >> 762992

Lymphoid neoplasia following connective tissue disease.

P M Banks, G A Witrak, D L Conn.   

Abstract

A retrospective review was undertaken to ascertain whether there are distinctive histopathologic features of the lymphoid neoplasms that occur in patients with previous connective tissue disease. Of 29 patients studied, 12 had malignant lymphoma with diffuse large-cell cytomorphology. Only 1 of these 12 had an immunoblastic cell type. The remaining 17 patients had neoplasia of a widely diverse nature. Six had lymphocytic lymphoma (one nodular poorly differentiated, three diffuse poorly differentiated, and three diffuse well differentiated), two had Hodgkin's disease, three had plasma cell myeloma, and six had chronic lymphocytic leukemia. Data fail to confirm a relationship between lymphoid proliferations with immunoblastic morphology and connective tissue diseases.

Entities:  

Mesh:

Year:  1979        PMID: 762992

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  10 in total

Review 1.  Rheumatoid arthritis, malignancy, and paraproteins.

Authors:  C Kelly; H Sykes
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

2.  Small B-cell lymphoma presenting as diffuse dural thickening with cranial neuropathies.

Authors:  Miguel Estevez; Charleen Chu; Misha Pless
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

Review 3.  What happens to patients with rheumatoid arthritis? The long-term outcome of treatment.

Authors:  T D Spector; D L Scott
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

4.  Lymphoproliferative malignancy in rheumatoid arthritis: a study of 20 cases.

Authors:  D P Symmons; M Ahern; P A Bacon; C F Hawkins; P L Amlot; E L Jones; P Prior; D L Scott
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

5.  The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up.

Authors:  J A Baltus; J W Boersma; A P Hartman; J P Vandenbroucke
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

6.  Development of malignant lymphoma in myoepithelial sialadenitis (Sjögren's syndrome).

Authors:  U Schmid; D Helbron; K Lennert
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

7.  Prognostic significance of paraproteinaemia in rheumatoid arthritis.

Authors:  C Kelly; G Baird; H Foster; H Hosker; I Griffiths
Journal:  Ann Rheum Dis       Date:  1991-05       Impact factor: 19.103

8.  Subcutaneous T-cell lymphoma in a patient with rheumatoid arthritis not treated with cytotoxic agents.

Authors:  Y Levy; J George; A Abraham; A Afek; A Livneh; Y Shoenfeld
Journal:  Clin Rheumatol       Date:  1997-11       Impact factor: 2.980

9.  Spontaneous remission of Epstein-Barr virus-negative non-Hodgkin's lymphoma after withdrawal of cyclosporine in a patient with refractory anemia.

Authors:  Masao Ogata; Hiroshi Kikuchi; Keiji Ono; Eiichi Ohtsuka; Ayako Gamachi; Kenji Kashima; Masaru Nasu
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

10.  Remission of arthritis and radiological improvement after combination therapy for non-Hodgkin's lymphoma in a patient with rheumatoid arthritis undergoing treatment with D-penicillamine.

Authors:  P Sheldon; J K Wood
Journal:  Ann Rheum Dis       Date:  1985-08       Impact factor: 19.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.